Oncology Grand Rounds: Teklab Gebregiworgis, PhD (UWO)
Zoom & London Regional Cancer Program (LRCP)
Room: A3-924A/B
800 Commissioners Rd. E.,
London, ON
Join the Department of Oncology for Teklab Gebregiworgis, PhD (UWO) presentation "Altering the regulation of KRAS GTPase cycle via Src and SHP2 creates a potential therapeutic vulnerability for pancreatic cancer," hosted by the Division of Experimental Oncology.
Dr. Gebregiworgis's presentation will:
- Describe the roles of SRC kinase and SHP2 phosphatase in modulationg KRAS activity;
- Examine the molecular mechanisms underlying SHP2 inhibitor action;
- Discuss the influence of oncogenic KRAS mutants on its GTPase cycle.
This event will be held virtually using Zoom. Please visit our Oncology Grand Rounds event page for more information about this event.
Kimberly.Scott@lhsc.on.ca